1.Antihypertensive Drug Medication Adherence of People with Disabilities and its Affecting Factors in Korea.
Jong Hyock PARK ; Youngsoo SHIN ; Sang Yi LEE ; Jae Hyun PARK
Journal of Preventive Medicine and Public Health 2007;40(3):249-258
OBJECTIVES: The aims of this study were to estimate the antihypertensive medication adherence in people with a disability and a history of taking antihypertensive medication, and to identify the factors affecting medication adherence. METHODS: The National Health Insurance claims data were linked with the National Disability Registry. People with a disability, who received a prescription of antihypertensives, were identified from a total of 85,098 cases. Cumulative medication adherence (CMA) was used as an indicator of medication adherence. A CMA > 80% was defined as appropriate medication adherence. Multiple logistic regression analysis was used to identify the factors affecting medication adherence. RESULTS: The average CMA in a total of 85,098 patients was 79.5%. The appropriate adherence (CMA > or =80%) rate was 54.5% and 20.5% of patients had a CMA < 50%. Multiple logistic regression analysis revealed that the probability of appropriate adherence decreased with decreasing number of prescription days per visit, increasing number of providers, the patients' residential area moving from urban to rural areas, and when patients have an internal organ disability, auditory impairment, mobility impairment. CONCLUSIONS: The adherence to antihypertensive medication in people with a disability is influenced by various socio-economic, clinical and regional factors. In particular, the disabled who have locomotive and communication disabilities and internal organ impairments have a higher probability of under-adherence to antihypertensive medication adherence in Korea.
Adult
;
Aged
;
Antihypertensive Agents/*administration & dosage
;
Comorbidity
;
Disabled Persons/*statistics & numerical data
;
Drug Utilization
;
Female
;
Health Services Accessibility
;
Humans
;
Insurance Claim Review
;
Korea/epidemiology
;
Logistic Models
;
Male
;
Middle Aged
;
National Health Programs
;
Patient Compliance/*statistics & numerical data
;
Residence Characteristics
;
Socioeconomic Factors
2.Considerations for the Management of Medial Orbital Wall Blowout Fracture.
Yong Ha KIM ; Youngsoo PARK ; Kyu Jin CHUNG
Archives of Plastic Surgery 2016;43(3):229-236
Recently, diagnoses of and operations for medial orbital blowout fracture have increased because of the development of imaging technology. In this article, the authors review the literature, and overview the accumulated knowledge about the orbital anatomy, fracture mechanisms, surgical approaches, reconstruction materials, and surgical methods. In terms of surgical approaches, transcaruncular, transcutaneous, and transnasal endoscopic approaches are discussed. Reconstruction methods including onlay covering, inlay implantation, and repositioning methods are also discussed. Consideration and understanding of these should lead to more optimal outcomes.
Diagnosis
;
Inlays
;
Orbit*
;
Orbital Fractures
;
Surgical Procedures, Operative
3.Seven Cases of Secondary Acute Leukemia Following Therapy of Breast Cancer.
Youngsoo CHOI ; Kihyun KIM ; Yonghwa UM ; Woo Chan PARK
Journal of Breast Cancer 2010;13(1):111-114
Secondary acute leukemia is a rare and fatal complication after the treatment of breast cancer. Recently, we experienced 2 cases of acute leukemia that had developed during the follow-up period after adjuvant therapy of breast cancer. In addition, retrospective analysis of medical records of St. Mary's hospital, the Catholic University of Korea, revealed another 5 cases of secondary leukemia following the treatment of breast cancer. Total 7 cases of secondary acute leukemia of breast cancer were reviewed and summarized according to their clinical characteristics. The mean age at diagnosis of primary breast cancer was 38.9 years (range, 16-49), and the average period from the completion of chemotherapy to the diagnosis of acute leukemia was 30.9 months (range, 11-40). The mean survival period of the 7 patients after diagnosis of leukemia was 4.6 months. Based on these findings, the risk of secondary leukemia following the treatment of breast should be considered in choosing chemotherapy and radiotherapy for the treatment of breast cancer especially in the young patients.
Breast
;
Breast Neoplasms
;
Follow-Up Studies
;
Humans
;
Korea
;
Leukemia
;
Medical Records
;
Retrospective Studies
4.Seven Cases of Secondary Acute Leukemia Following Therapy of Breast Cancer.
Youngsoo CHOI ; Kihyun KIM ; Yonghwa UM ; Woo Chan PARK
Journal of Breast Cancer 2010;13(1):111-114
Secondary acute leukemia is a rare and fatal complication after the treatment of breast cancer. Recently, we experienced 2 cases of acute leukemia that had developed during the follow-up period after adjuvant therapy of breast cancer. In addition, retrospective analysis of medical records of St. Mary's hospital, the Catholic University of Korea, revealed another 5 cases of secondary leukemia following the treatment of breast cancer. Total 7 cases of secondary acute leukemia of breast cancer were reviewed and summarized according to their clinical characteristics. The mean age at diagnosis of primary breast cancer was 38.9 years (range, 16-49), and the average period from the completion of chemotherapy to the diagnosis of acute leukemia was 30.9 months (range, 11-40). The mean survival period of the 7 patients after diagnosis of leukemia was 4.6 months. Based on these findings, the risk of secondary leukemia following the treatment of breast should be considered in choosing chemotherapy and radiotherapy for the treatment of breast cancer especially in the young patients.
Breast
;
Breast Neoplasms
;
Follow-Up Studies
;
Humans
;
Korea
;
Leukemia
;
Medical Records
;
Retrospective Studies
5.A case of anaphylactic reaction to oral cefaclor.
Sang Hoon KIM ; Jung Hee CHOI ; Youngsoo AHN ; Hae Sim PARK
Korean Journal of Medicine 2003;65(Suppl 3):S882-S884
Antibiotics induced anaphylaxis is one of the most acute and potentially fatal drug-related adverse reactions. Cefaclor, an oral second-generation cephalosporin with a beta lactam ring, is used various infectious diseases of the respiratory tract. Few cases of cefaclor anaphylaxis have been rarely reported. Here we report a case of anaphylactic reaction to cefaclor in a 40-year-old female patient. She developed systemic reaction comprised of generalized hives with itching, vomiting, abdominal pain, and hypotension. She was treated on our ER with intravenous fluids, intravenous diphenhydramine and subcutaneous epinephrine. Since four month ago, she had developed generalized pruritic eruptions with flu-like symptoms. The rash resolved the same day after treated with intravenous diphenhydramine. On detailed history taking for medication, we had known that she received a same prescription containing a cefaclor at every episode. Subsequently we tested the patient with cefaclor and conducted an intradermal skin test and an ELISA to cefaclor-HSA conjugate. She showed a positive response. Cefaclor is widely used for common infections, physicians should anticipate the possibility of anaphylactic reaction treated with this agent, particularly in cases of multiple exposure.
Abdominal Pain
;
Adult
;
Anaphylaxis*
;
Anti-Bacterial Agents
;
Cefaclor*
;
Communicable Diseases
;
Diphenhydramine
;
Enzyme-Linked Immunosorbent Assay
;
Epinephrine
;
Exanthema
;
Female
;
Humans
;
Hypotension
;
Immunoglobulin E
;
Prescriptions
;
Pruritus
;
Respiratory System
;
Skin Tests
;
Urticaria
;
Vomiting
6.Management of allergic patients during severe acute respiratory syndrome coronavirus-2 pandemic
Youngsoo LEE ; Jae-Hyuk JANG ; Hae-Sim PARK
Allergy, Asthma & Respiratory Disease 2021;9(3):115-123
A novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 in China. The mutated coronavirus spread worldwide, and some patients infected with SARS-CoV-2 developed coronavirus disease 2019 (COVID-19) manifested with upper respiratory infection, pneumonia, or respiratory distress. Since the SARS-CoV-2 pandemic was declared with surging confirmed cases and mortality of COVID-19 worldwide, it has reshaped our way of living and how to manage patients with allergic diseases. The medical staff, including allergy specialists, has been at the forefront of fighting against the SARSCoV-2 pandemic and is struggling to guarantee safety to themselves and their patients. Thanks to vigorous research into the relationship between SARS-CoV-2 and allergic diseases, we have become able to treat allergic patients with the best of evidence to date. The clinician should make a careful decision on each clinical situation with regard to patient characteristics, local and national circumstances as well as the knowledge we have, since it is still limited. We hope further efforts to identify the nature of SARS-CoV-2 and COVID-19 clearer and effective SARS-CoV-2 vaccination will soon remove the grim picture of the worldwide pandemic and bring us back to normal.
7.Which Factors Associated With Activated Eosinophils Contribute to the Pathogenesis of Aspirin-Exacerbated Respiratory Disease?
Youngwoo CHOI ; Youngsoo LEE ; Hae Sim PARK
Allergy, Asthma & Immunology Research 2019;11(3):320-329
Eosinophils have long been recognized as a central effector cell in the lungs of asthmatic patients. They contribute to airway inflammation and remodeling through releasing several molecules such as cytokines, granule proteins, lipid mediators and extracellular traps/vesicles. Repeated evidence reveals that intense eosinophil infiltration in upper and lower airway mucosae contributes to the pathogenesis of aspirin-exacerbated respiratory disease (AERD). Persistent eosinophilia is found to be associated with type 2 immune responses, cysteinyl leukotriene overproduction and eosinophil-epithelium interactions. This review highlights recent findings about key mechanisms of eosinophil activation in the airway inflammation of AERD. In addition, current biologics (targeting type 2 immune responses) were suggested to control eosinophilic inflammation for AERD patients.
8.Solitary Peutz-Jeghers type harmartomatous polyp in duodenum with gastric foveolar epithelium: a case report
Eugene CHOI ; Junghwan LEE ; Youngsoo PARK
Journal of Pathology and Translational Medicine 2023;57(2):128-131
Peutz-Jeghers type hamartomatous polyp is known to be associated with Peutz-Jeghers syndrome, which shows characteristic multiple hamartomatous polyp involvement in the gastrointestinal tract, combined with mucocutaneous symptom, familial history of Peutz- Jeghers syndrome or STK11/LTB1 mutation. However, some cases showing histologic appearance of the polyps discovered in Peutz- Jeghers syndrome while lacking other diagnostic criteria of the syndrome have been reported, and these are called solitary Peutz- Jeghers type polyps. Herein, we report a case of solitary Peutz-Jeghers type polyp covered with heterotopic epithelium. The patient was 47-year-old female without any mucocutaneous symptoms nor familial history of Peutz-Jeghers syndrome. Microscopic examination revealed Peutz-Jeghers type hamartomatous polyp in duodenum covered with gastric type foveolar epithelium. Considering the definition of hamartomatous polyp, which is, the abnormal overgrowth of the indigenous epithelial component, the histological feature of current case is noteworthy in a point that it shows proliferation of heterotopic component, rather than the indigenous component.
9.Piperidylmethyloxychalcone improves immune-mediated acute liver failure via inhibiting TAK1 activity.
Sun Hong PARK ; Jeong Ah KWAK ; Sang Hun JUNG ; Byeongwoo AHN ; Won Jea CHO ; Cheong Yong YUN ; Chang Seon NA ; Bang Yeon HWANG ; Jin Tae HONG ; Sang Bae HAN ; Youngsoo KIM
Experimental & Molecular Medicine 2017;49(11):e392-
Mice deficient in the toll-like receptor (TLR) or the myeloid differentiation factor 88 (MyD88) are resistant to acute liver failure (ALF) with sudden death of hepatocytes. Chalcone derivatives from medicinal plants protect from hepatic damages including ALF, but their mechanisms remain to be clarified. Here, we focused on molecular basis of piperidylmethyloxychalcone (PMOC) in the treatment of TLR/MyD88-associated ALF. C57BL/6J mice were sensitized with D-galactosamine (GalN) and challenged with Escherichia coli lipopolysaccharide (LPS, TLR4 agonist) or oligodeoxynucleotide containing unmethylated CpG motif (CpG ODN, TLR9 agonist) for induction of ALF. Post treatment with PMOC sequentially ameliorated hepatic inflammation, apoptosis of hepatocytes, severe liver injury and shock-mediated death in ALF-induced mice. As a mechanism, PMOC inhibited the catalytic activity of TGF-β-activated kinase 1 (TAK1) in a competitive manner with respect to ATP, displaced fluorescent ATP probe from the complex with TAK1, and docked at the ATP-binding active site on the crystal structure of TAK1. Moreover, PMOC inhibited TAK1 auto-phosphorylation, which is an axis in the activating pathways of nuclear factor-κB (NF-κB) or activating protein 1 (AP1), in the liver with ALF in vivo or in primary liver cells stimulated with TLR agonists in vitro. PMOC consequently suppressed TAK1-inducible NF-κB or AP1 activity in the inflammatory injury, an early pathogenesis leading to ALF. The results suggested that PMOC could contribute to the treatment of TLR/MyD88-associated ALF with the ATP-binding site of TAK1 as a potential therapeutic target.
Adenosine Triphosphate
;
Animals
;
Apoptosis
;
Catalytic Domain
;
Chalcone
;
Death, Sudden
;
Escherichia coli
;
Hepatocytes
;
In Vitro Techniques
;
Inflammation
;
Liver
;
Liver Failure, Acute*
;
Mice
;
Myeloid Differentiation Factor 88
;
Phosphotransferases
;
Plants, Medicinal
;
Toll-Like Receptors
10.A Case of Pulmonary Edema Due to the Severe Airway Obstruction by the Burglary Attack.
Sang Won PARK ; Young Ji KIM ; Sang Hoon KIM ; Youngsoo AHN
Tuberculosis and Respiratory Diseases 2004;56(5):532-535
Acute fulminating pulmonary edema was developed in 20 year old female following an acute airway obstruction due to a burglary attack on neck with bare hands. The pathogenesis of pulmonary edema is related to the alveolar and capillary damage induced by the severe negative pressure generated by attempting to inspire against the closed upper airway. This female responded to fluid restriction and oxygen supply. To our knowledge, pulmonary edema caused by man has never been reported in the literature.
Airway Obstruction*
;
Capillaries
;
Female
;
Hand
;
Humans
;
Neck
;
Oxygen
;
Pulmonary Edema*
;
Young Adult